ARAAX
Price
$26.92
Change
+$0.25 (+0.94%)
Updated
Oct 20 closing price
Net Assets
1.4B
DRRCX
Price
$16.17
Change
+$0.17 (+1.06%)
Updated
Oct 20 closing price
Net Assets
866.35M
Interact to see
Advertisement

ARAAX vs DRRCX

Header iconARAAX vs DRRCX Comparison
Open Charts ARAAX vs DRRCXBanner chart's image
Horizon Active Risk Assist® A
Price$26.92
Change+$0.25 (+0.94%)
VolumeN/A
Net Assets1.4B
BNY Mellon Global Real Return - C
Price$16.17
Change+$0.17 (+1.06%)
VolumeN/A
Net Assets866.35M
ARAAX vs DRRCX Comparison Chart in %
View a ticker or compare two or three
VS
ARAAX vs. DRRCX commentary
Oct 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARAAX is a Hold and DRRCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
ARAAX has more cash in the bank: 1.4B vs. DRRCX (866M). DRRCX pays higher dividends than ARAAX: DRRCX (3.93) vs ARAAX (0.47). ARAAX was incepted earlier than DRRCX: ARAAX (10 years) vs DRRCX (15 years). DRRCX (2.00) is less costly to investors than ARAAX (1.43). DRRCX is a more actively managed with annual turnover of: 77.47 vs. ARAAX (66.00). DRRCX has a lower initial minimum investment than ARAAX: DRRCX (1000) vs ARAAX (2500). DRRCX annual gain was more profitable for investors over the last year : 8.32 vs. ARAAX (-0.81). ARAAX return over 5 years is better than : 34.64 vs. DRRCX (19.06).
ARAAXDRRCXARAAX / DRRCX
Total Expense Ratio1.431.9374%
Annual Report Gross Expense Ratio1.432.0072%
Fund Existence10 years15 years-
Gain YTD12.35410.000124%
Front LoadN/AN/A-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets1.4B866M161%
Annual Yield % from dividends0.473.9312%
Returns for 1 year-0.818.32-10%
Returns for 3 years36.2420.95173%
Returns for 5 years34.6419.06182%
Returns for 10 years45.0437.36121%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VTGN4.480.43
+10.62%
VistaGen Therapeutics
HSCS3.440.11
+3.30%
HeartSciences Inc
UTHR432.69-0.65
-0.15%
United Therapeutics Corp
GENI11.78-0.15
-1.26%
Genius Sports Limited
ARQQ39.56-1.93
-4.65%
Arqit Quantum Inc